Talleyrand IntelligenceThe facts. Your judgement.

Astrana Health Q2 2026 — the filed record

CALL 2026-08-06 RECORD PUBLISHED 2026-08-18 FILING RECORD · TRANSCRIPT ANALYSIS PENDING
Source Statements — No Public Why FoundManagement is quoted · no explanatory analyst or media source was found
Management
Management · earnings release

Brandon Sim · earnings statement

“Our second quarter results reflect the strength of Astrana’s physician-centric, AI-native healthcare operating system and the disciplined execution of our team,”
Brandon SimPresident and Chief Executive Officer of Astrana Health8-K 2026-08-06 · EX-99.1 ↗
Sourced Takeaways5 takeaways · every bullet sourced
  1. Net income was $19.7M; versus $9.4M a year earlier; +109% YoY.
    Filed8-K 2026-08-06 · EX-99.1
  2. Adjusted EBITDA was $68.9M; versus $48.1M a year earlier; +43% YoY.
    Filed8-K 2026-08-06 · EX-99.1
  3. Revenue was $972.5M; versus $654.8M a year earlier; +49% YoY.
    Filed8-K 2026-08-06 · EX-99.1
  4. Diluted EPS (GAAP) was $0.40; versus $0.19 a year earlier; +111% YoY.
    Filed8-K 2026-08-06 · EX-99.1
  5. Adjusted EPS was $0.80; versus $0.55 a year earlier; +45% YoY.
    Filed8-K 2026-08-06 · EX-99.1
The NumbersReported · published precision · every figure sourced
MetricQ2 2026Prior yrYoYFY Guide
Net income$19.7M$9.4M+109%
Adjusted EBITDA$68.9M$48.1M+43%
Revenue$972.5M$654.8M+49%
Diluted EPS (GAAP)$0.40$0.19+111%
Adjusted EPS$0.80$0.55+45%
CMS ROWS ARE GROUND TRUTH, INDEPENDENT OF COMPANY REPORTING · PRECISION PER BRAND SPEC
The DocumentsEverything this record is built from
The filing every figure on this page is read from.
8-K 2026-08-06 · EX-99.1